Patent & IP news for May 13, 2012

Fat lips and lost writs: CJEU refuses bids by L'Oreal and Helena Rubinstein to register Botox-like trade marks from ipkitten.blogspot.com

What the AmeriKat would look like
if she ever tried Botox.
 Its not a good look for her. Last Thursday, after seven years of coursing through various boards of appeals and courts in Europe, the ...

Share via E–mail | Twitter | Facebook

Functional Alcohol: The History of Bourbon and the Mystery of Aesthetic Functionality in the Sixth Circuit of the United States from ipkitten.blogspot.com


The Kats and their 8,997 friends have all been de-herded and gone back to their homes around the world after what appeared to be quite a successful INTA.  It was this Kat’s inaugural ...

Share via E–mail | Twitter | Facebook

Copyright at the Edge of Artistic Creativity from www.iposgoode.ca

Part of what makes studying the creative arts from a legal perspective so fascinating is the diversity of forms that art takes, and the ways in which law is sometimes underprepared to deal with issues ...

Share via E–mail | Twitter | Facebook

An explanation for geeks: why Google hasn't won anything against Oracle's Java APIs from www.fosspatents.com

I just reported on Oracle's and Google's competing proposals for determining copyright damages.

This present blog post may be of interest to many of those who follow the Oracle v. Google trial, but ...

Share via E–mail | Twitter | Facebook

Conference & CLE Calendar from www.patentdocs.org

May 15, 2012 - FDA's New Biosimilar Guidances (Law Seminars International) - 3:00 - 4:00 pm (Eastern) May 16, 2012 - Patent-Eligible Subject Matter after Mayo v. Prometheus: Exploring the Path Forward (George Washington University Law ...

Share via E–mail | Twitter | Facebook

Court Report from www.patentdocs.org

By Sherri Oslick -- About Court Report: Each week we will report briefly on recently filed biotech and pharma cases. Esoterix Genetic Laboratories, LLC v. Life Technologies Corp. et al. 1:12-cv-00411; filed April 26, 2012 ...

Share via E–mail | Twitter | Facebook